Abstract
46 - Medications mostly associated with urinary retention: Assessment of the EudraVigilance (EV) and the Food and Drug Administration (FDA) pharmacovigilance database entries
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have